文献速递支持与姑息治疗

癌症患者COVID-19感染风险、种族差异与结局分析

Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection.
PubMed 文献 · JAMA Oncol · 2021-01-01

近期癌症诊断者感染风险显著升高(aOR 7.14),非洲裔患者种族差异显著,癌症合并COVID-19者住院率47.46%、死亡率14.93%,均显著劣于对照。

要点

  • 近期癌症诊断者COVID-19感染风险显著升高,白血病、非霍奇金淋巴瘤和肺癌关联最强。
  • 非洲裔近期癌症患者感染风险显著高于白人,乳腺癌差异最大(aOR 5.44)。
  • 癌症合并COVID-19者住院率和死亡率显著高于无癌症的COVID-19患者及无COVID-19的癌症患者。

核心结论

  • 癌症患者COVID-19感染风险显著增加且结局更差,非洲裔患者中种族差异进一步加剧。

研究设计与样本

  • 暴露组为特定癌症诊断患者,非暴露组为无该癌症患者,评估13种常见癌症的COVID-19感染风险及不良结局。

主要发现

  • 近期癌症诊断者COVID-19感染风险显著升高(aOR 7.14,95%CI 6.91-7.39,P<.001)。
  • 近期诊断白血病(aOR 12.16,95%CI 11.03-13.40)、非霍奇金淋巴瘤(aOR 8.54,95%CI 7.80-9.36)、肺癌(aOR 7.66,95%CI 7.07-8.29)关联最强,甲状腺癌最弱(aOR 3.10,95%CI 2.47-3.87)。
  • 非洲裔近期癌症患者感染风险显著高于白人,乳腺癌差异最大(aOR 5.44,95%CI 4.69-6.31),其次前列腺癌(aOR 5.10,95%CI 4.34-5.98)、结直肠癌(aOR 3.30,95%CI 2.55-4.26)、肺癌(aOR 2.53,95%CI 2.10-3.06)。
  • 癌症合并COVID-19者住院率47.46%、死亡率14.93%,显著高于无癌症的COVID-19患者(住院24.26%、死亡5.26%)及无COVID-19的癌症患者(住院12.39%、死亡4.03%)(P<.001)。

临床怎么用

  • 应将癌症患者特别是近期诊断者作为疫情控制的重点保护和监测对象。
  • 对非洲裔癌症患者需关注感染风险的种族差异,加强防护和筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Patients with specific cancers may be at higher risk than those without cancer for coronavirus disease 2019 (COVID-19) and its severe outcomes. At present, limited data are available on the risk, racial disparity, and outcomes for COVID-19 illness in patients with cancer. OBJECTIVES: To investigate how patients with specific types of cancer are at risk for COVID-19 infection and its adverse outcomes and whether there are cancer-specific race disparities for COVID-19 infection. DESIGN, SETTING, AND PARTICIPANTS: This retrospective case-control analysis of patient electronic health records included 73.4 million patients from 360 hospitals and 317 000 clinicians across 50 US states to August 14, 2020. The odds of COVID-19 infections for 13 common cancer types and adverse outcomes were assessed. EXPOSURES: The exposure groups were patients diagnosed with a specific cancer, whereas the unexposed groups were patients without the specific cancer. MAIN OUTCOMES AND MEASURES: The adjusted odds ratio (aOR) and 95% CI were estimated using the Cochran-Mantel-Haenszel test for the risk of COVID-19 infection. RESULTS: Among the 73.4 million patients included in the analysis (53.6% female), 2 523 920 had at least 1 of the 13 common cancers diagnosed (all cancer diagnosed within or before the last year), and 273 140 had recent cancer (cancer diagnosed within the last year). Among 16 570 patients diagnosed with COVID-19, 1200 had a cancer diagnosis and 690 had a recent cancer diagnosis of at least 1 of the 13 common cancers. Those with recent cancer diagnosis were at significantly increased risk for COVID-19 infection (aOR, 7.14 [95% CI, 6.91-7.39]; P < .001), with the strongest association for recently diagnosed leukemia (aOR, 12.16 [95% CI, 11.03-13.40]; P < .001), non-Hodgkin lymphoma (aOR, 8.54 [95% CI, 7.80-9.36]; P < .001), and lung cancer (aOR, 7.66 [95% CI, 7.07-8.29]; P < .001) and weakest for thyroid cancer (aOR, 3.10 [95% CI, 2.47-3.87]; P < .001). Among patients with recent cancer diagnosis, African Americans had a significantly higher risk for COVID-19 infection than White patients; this racial disparity was largest for breast cancer (aOR, 5.44 [95% CI, 4.69-6.31]; P < .001), followed by prostate cancer (aOR, 5.10 [95% CI, 4.34-5.98]; P < .001), colorectal cancer (aOR, 3.30 [95% CI, 2.55-4.26]; P < .001), and lung cancer (aOR, 2.53 [95% CI, 2.10-3.06]; P < .001). Patients with cancer and COVID-19 had significantly worse outcomes (hospitalization, 47.46%; death, 14.93%) than patients with COVID-19 without cancer (hospitalization, 24.26%; death, 5.26%) (P < .001) and patients with cancer without COVID-19 (hospitalization, 12.39%; death, 4.03%) (P < .001). CONCLUSIONS AND RELEVANCE: In this case-control study, patients with cancer were at significantly increased risk for COVID-19 infection and worse outcomes, which was further exacerbated among African Americans. These findings highlight the need to protect and monitor patients with cancer as part of the strategy to control the pandemic.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Wang Q, Berger NA, Xu R, et al. Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection. JAMA Oncol. 2021. PMID: 33300956. doi:10.1001/jamaoncol.2020.6178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。